Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Marlyn J Mayo"'
Autor:
Surain B. Roberts, Woo Jin Choi, Lawrence Worobetz, Catherine Vincent, Jennifer A. Flemming, Angela Cheung, Karim Qumosani, Mark Swain, Dusanka Grbic, Hin Hin Ko, Kevork M. Peltekian, Lusine Abrahamyan, Monika Saini, Kattleya Tirona, Bishoi Aziz, Ellina Lytvyak, Pietro Invernizzi, Cyriel Y. Ponsioen, Tony Bruns, Nora Cazzagon, Keith Lindor, George N. Dalekos, Nikolaos K. Gatselis, Xavier Verhelst, Annarosa Floreani, Christophe Corpechot, Marlyn J. Mayo, Cynthia Levy, Maria-Carlota Londoño, Pier M. Battezzati, Albert Pares, Frederik Nevens, Adriaan van der Meer, Kris V. Kowdley, Palak J. Trivedi, Ana Lleo, Douglas Thorburn, Marco Carbone, Nazia Selzner, Aliya F. Gulamhusein, Harry LA. Janssen, Aldo J. Montano-Loza, Andrew L. Mason, Gideon M. Hirschfield, Bettina E. Hansen
Publikováno v:
JHEP Reports, Vol 6, Iss 10, Pp 101168- (2024)
Background & Aims: Biochemical response to ursodeoxycholic acid (UDCA) therapy is associated with good prognosis in people living with primary biliary cholangitis (PBC). Biochemical response is typically assessed early in disease and it is not known
Externí odkaz:
https://doaj.org/article/8d1c44ac78ae4a3ebc2eca8571c39ace
Autor:
Elizabeth D Ferucci, Kathy J Hurlburt, Marlyn J Mayo, Stephen Livingston, Heike Deubner, James Gove, Julia Plotnik, Brian J McMahon
Publikováno v:
Canadian Journal of Gastroenterology, Vol 25, Iss 1, Pp 21-27 (2011)
BACKGROUND: In autoimmune hepatitis (AIH) patients treated with azathioprine, the utility of measuring thiopurine methyltransferase (TPMT) and azathioprine metabolites has been limited.
Externí odkaz:
https://doaj.org/article/2193577c877442ef8f2b0b103c496ce1
Autor:
Robyn von Maltzahn, Marlyn J. Mayo, Helen T. Smith, April Thompson, Sugato Das, Andrea Ribeiro de Souza, Edoardo Lisi, Cynthia Levy, Megan M. McLaughlin, David Jones
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-10 (2024)
Abstract Background Cholestatic pruritus and fatigue are debilitating conditions associated with primary biliary cholangitis (PBC) and can significantly impact patients’ quality of life. Pruritus in PBC often worsens at night and patients frequentl
Externí odkaz:
https://doaj.org/article/4d1af5d6eaee470a8aa825e7746d9486
Autor:
Maren H. Harms, Gideon M. Hirschfield, Annarosa Floreani, Marlyn J. Mayo, Albert Parés, Alexander Liberman, Elizabeth Smoot Malecha, Richard Pencek, Leigh MacConell, Bettina E. Hansen
Publikováno v:
JHEP Reports, Vol 3, Iss 1, Pp 100191- (2021)
Background & Aims: Biochemical markers, including GLOBE score and aspartate aminotransferase-to-platelet ratio index (APRI), are used to stratify risk in patients with primary biliary cholangitis (PBC). This study aimed to evaluate the effects of obe
Externí odkaz:
https://doaj.org/article/95e438775f4a44889ce3861625a16d64
Autor:
Marlyn J. Mayo, Alan J. Wigg, Barbara A. Leggett, Hays Arnold, Alexander J. Thompson, Martin Weltman, Elizabeth J. Carey, Andrew J. Muir, Lei Ling, Stephen J. Rossi, Alex M. DePaoli
Publikováno v:
Hepatology Communications, Vol 2, Iss 9, Pp 1037-1050 (2018)
Patients with primary biliary cholangitis (PBC) who had an inadequate response to ursodiol have few treatment options. Alkaline phosphatase (ALP) and bilirubin levels correlate with the risk of liver transplant or death in PBC patients. Fibroblast gr
Externí odkaz:
https://doaj.org/article/4cf97fa6121848f28eac1a691058cf71
Autor:
Cynthia Levy, Stuart Kendrick, Christopher L. Bowlus, Atsushi Tanaka, David Jones, Andreas E. Kremer, Marlyn J. Mayo, Nazneen Haque, Robyn von Maltzahn, Matthew Allinder, Brandon Swift, Megan M. McLaughlin, Gideon M. Hirschfield
GLIMMER assessed dose-response, efficacy, and safety of linerixibat, an ileal bile acid transporter inhibitor in development for cholestatic pruritus associated with primary biliary cholangitis (PBC).GLIMMER was a Phase 2b, multicenter, randomized, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ede81694969fc43651ed758e245fb69a
https://doi.org/10.5167/uzh-225261
https://doi.org/10.5167/uzh-225261
Autor:
Christopher L. Bowlus, Michael R. Galambos, Richard J. Aspinall, Gideon M. Hirschfield, David E.J. Jones, Yvonne Dörffel, Stuart C. Gordon, Stephen A. Harrison, Andreas E. Kremer, Marlyn J. Mayo, Paul J. Thuluvath, Cynthia Levy, Mark G. Swain, Guy W. Neff, David A. Sheridan, Carmen M. Stanca, Christoph P. Berg, Aparna Goel, Mitchell L. Shiffman, John M. Vierling, Pol Boudes, Alexandra Steinberg, Yun-Jung Choi, Charles A. McWherter
Publikováno v:
Journal of Hepatology. 77:353-364
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30eb0284f4c72c499f63b694e0199fe6
https://doi.org/10.1016/j.jhep.2022.02.033
https://doi.org/10.1016/j.jhep.2022.02.033
Autor:
Marlyn J. Mayo
Publikováno v:
Yamada's Atlas of Gastroenterology. :476-482
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8385d7969cf2245a3cc668c10e0719e6
https://doi.org/10.1002/9781119600527.ch52
https://doi.org/10.1002/9781119600527.ch52
Autor:
Carla F, Murillo Perez, Alessio, Gerussi, Palak J, Trivedi, Christophe, Corpechot, Adriaan J, van der Meer, Pier, Maria Battezzati, Keith D, Lindor, Frederik, Nevens, Kris V, Kowdley, Tony, Bruns, Nora, Cazzagon, Annarosa, Floreani, Atsushi, Tanaka, Xiong, Ma, Andrew L, Mason, Aliya, Gulamhusein, Cyriel Y, Ponsioen, Marco, Carbone, Ana, Lleo, Marlyn J, Mayo, George N, Dalekos, Nikolaos K, Gatselis, Douglas, Thorburn, Xavier, Verhelst, Albert, Parés, Harry L A, Janssen, Gideon M, Hirschfield, Bettina E, Hansen, Pietro, Invernizzi, Willem J, Lammers
Publikováno v:
European Journal of Gastroenterology and Hepatology, 35(1), 112-119. Lippincott Williams & Wilkins
Background and aims The are geographic variations in the incidence and prevalence of primary biliary cholangitis (PBC). The aim was to explore whether clinical outcomes of patients within Western Europe differ according to geographical region. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4fb0ee5829af4ca3a1704b8ba980d034
https://pure.eur.nl/en/publications/b7aa98f2-a19b-447a-b5ba-03b27f7812eb
https://pure.eur.nl/en/publications/b7aa98f2-a19b-447a-b5ba-03b27f7812eb
Autor:
Aliya Gulamhusein, Nora Cazzagon, Xavier Verhelst, Andrew Mason, Cyriel Y. Ponsioen, George N. Dalekos, Keith D. Lindor, Frederik Nevens, Palak J. Trivedi, Adriaan J. van der Meer, Kris V. Kowdley, Willem J Lammers, Olivier Chazouillères, Ana Lleo, Douglas Thorburn, Nikolaos K. Gatselis, Bettina E. Hansen, Carla F. Murillo Perez, Tony Bruns, Gideon M. Hirschfield, Pietro Invernizzi, Annarosa Floreani, Christophe Corpechot, Marco Carbone, Marlyn J. Mayo, Albert Parés, Pier Maria Battezzati, Harry L.A. Janssen
Publikováno v:
European journal of gastroenterology & hepatology, 33(1S Suppl 1), e266-e273. Lippincott Williams & Wilkins
European journal of gastroenterology & hepatology, 33(1S Suppl 1), e266-e273. Lippincott Williams and Wilkins
European journal of gastroenterology & hepatology, 33(1S Suppl 1), e266-e273. Lippincott Williams and Wilkins
BACKGROUND: Opportunity to redefine the care journeys for those living with primary biliary cholangitis (PBC) includes facilitating access to enhanced (PBC-dedicated) programmes by nonspecialist risk 'flagging' of patients. OBJECTIVE: To develop a no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06c1e95ea351be68d7e6b6a9cb6efc49
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85123807520&origin=inward
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85123807520&origin=inward